Showing 1 - 1 results of 1 for search 'A.K. Conlin', query time: 0.02s Refine Results
  1. 1
    Cutaneous responses in HER2+ metastatic breast cancer: A retrospective case series of a Phase 1b study of Tucatinib, an Oral HER2-specific inhibitor in combination with Capecitabine and/or Trastuzumab in third-line or later treatment

    Cutaneous responses in HER2+ metastatic breast cancer: A retrospective case series of a Phase 1b study of Tucatinib, an Oral HER2-specific inhibitor in combination with Capecitabin... by A.K. Conlin, B.M. Chun, V.F. Borges, N.M. Moxon, H.J. Parris, L.N. Walker, R.K. Murthy

    Published 2022-09-01
    Get full text
    Article

Search Tools: